Index Entries

2025 Results
TitleIS Publication Date
Perspective: Universal Masking in Hospitals in the Covid-19 EraMay 21, 2020
Petition For Administrative Action Regarding COVID-19 modRNA Vaccines of Pfizer & ModernaJanuary 21, 2025
Pfizer clinical trial: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness StudyFirst posted April 19, 2021; last updated June 27, 2023
Pfizer Corporate Rap SheetLast updated February 3, 2017
Pfizer director admits vaccine was never tested on preventing transmissionOctober 11, 2022
Pfizer DNA Detected in Colon Cancer Biopsy: Kevin McKernan Presents FindingsOctober 19, 2024
Pfizer Medical, Scientific & Patient Education Grant Transparency
Pfizer trial paper: Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineDecember 10, 2020
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical TestingWinter 2024
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccinesNovember 6, 2024
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZenecaupdated April 7, 2023
Physical interventions to interrupt or reduce the spread of respiratory virusesJanuary 30, 2023
Physicians Declaration – Global COVID Summit, Rome, ItalySeptember 2021
Physicians Declaration IIOctober 29, 2021
Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 eraNovember 20, 2021
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working GroupMarch 16, 2021
Plaintiffs Motion for Preliminary Injunction: America’s Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the US Department of Health and Human ServicesJuly 19, 2021
Plan B Public Health Infrastructure and Operations Oversight Reform for AmericaJanuary 5, 2021
Planting Evidence & Masking the FraudJune 1, 2020
Plastic waste release caused by COVID-19 and its fate in the global oceanNovember 8, 2021
Pneumonia and Influenza Mortality Surveillance from the National Center for Health Statistics Mortality Surveillance System
Poll: Majority of Democrats say the unvaccinated should be confined to homeJanuary 25, 2022
Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report StudiesDecember 14, 2021
Position Paper – COVID-19 Vaccine for ChildrenNovember 24, 2021
Position Paper: The Science and the Ethics Regarding the Risk Posed by Non-Vaccinated IndividualsAugust 11, 2021
Position paper: Use of facemasks in the community as a means to curb the spread of the COVID-19 virusMarch 31, 2022
Position Statement on COVID-19 Vaccines for ChildrenMay 8, 2024
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyJune 24, 2021
Possible toxicity of chronic carbon dioxide exposure associated with face mask use, particularly in pregnant women, children and adolescents – A scoping reviewMarch 2, 2023
Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patientsOctober 11, 2021
Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 ImmunizationNovember 10, 2023
Post–COVID-19 Condition Fatigue Outcomes Among Danish ResidentsOctober 7, 2024
Postacute sequelae of SARS-CoV-2 in the population: Risk factors and vaccinesMarch 17, 2025
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series studyJuly 28, 2022
Postmortem investigation of fatalities following vaccination with COVID-19 vaccinesSeptember 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionOctober 5, 2021
Potential adverse effects of nanoparticles on the reproductive systemDecember 11, 2018
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)May 31, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialJune 24, 2021
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19August 23, 2022
Potential health risks of mRNA-based vaccine therapy: A hypothesisJanuary 25, 2023
Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 PandemicJune 2023
Potential toxicity of nanoparticles on the reproductive system animal modelsSeptember 25, 2021
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in childrenAugust 18, 2021
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illnessFebruary 3, 2022
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic SamplesMay 22, 2020
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, CaliforniaJanuary 10, 2022
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansDecember 11, 2020
Pregnancy-Related Deaths in the US, 2018-2022April 9, 2025
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic SymptomsFebruary 24, 2022